Searchable abstracts of presentations at key conferences in endocrinology

ea0056p805 | Pituitary - Clinical | ECE2018

Long-term outcomes of different treatments for cushing disease: a retrospective study

Molero Inmaculada Gonzalez , Abuin Jose , Marin Monserrat Gonzalo , Doulatram Viyei , Arnes Juan Garcia , Arraez Miguel Angel , Olveira Gabriel

Introduction: Cushing disease (CD) results from excessive exposure to glucocorticoids caused by an adrenocorticotropic hormone–secreting pituitary tumor. Inadequately treated CD is associated with significant morbidity and elevated mortality.Objetive: The study purpose was to describe the long term treatment outcomes for CD patients in our hospital.Methods: Retrospective analysis of the records of 36 patients with Cushing dise...

ea0056p827 | Pituitary - Clinical | ECE2018

Benefits of pre-surgical treatment with somatostatin analogs in naive patients with acromegaly

Cornejo-Pareja Isabel M , Maraver-Selfa Silvia , Munoz-Garach Araceli , Gonzalez-Molero Inmaculada , Mancha-Doblas Isabel , Tinahones Francisco

Introduction: Somatostatin analogs (SS-analogs) are the treatment option when there is a persistent disease despite surgical intervention. They can be also recommended as a first line treatment if surgery is not appropriate (non-curative or contraindicated surgery).Objetive: To evaluate the effect of first-generation SS-analogs (lanreotide and octreotide) on tumour shrinkage and biochemical control in naive patients.Methods: We per...

ea0081p124 | Endocrine-Related Cancer | ECE2022

Hirsutism as the first manifestation of a mesonephric-like adenocarcinoma of the ovary: the first case with positive androgen receptors

Timon Iciar Martin , Ugalde-Abiega Beatriz , Zubillaga Mikaela , Moreno-Ruiz Inmaculada , Huguet Isabel , Meizoso-Pita Olalla , Trivino Yannuzzi Vanessa , Sevillano-Collantes Cristina

Mesonephric adenocarcinoma (MA) is an uncommon gynecologic tumor that are thought to arise from embryonal remnants of the mesonephric ducts, also known as Wolffian ducts. Mesonephric-like adenocarcinoma (MLA), despite absence of Wolffian origin, have similar morphology and immunophenotype and exhibit molecular aberrations like MA. These tumors are generally negative for estrogen and progesterone receptor.Case Report: An 83-year-old Spanish female was ref...

ea0081p687 | Pituitary and Neuroendocrinology | ECE2022

Plurihormonal pituitary macroadenoma, co −secreting TSH/GH/and prolactin: a clinical challenge

Bilbao Garay Ismene , Egana Nerea , Perez De Ciriza Maite , Chinchurreta Laura , Elias Cristina , Venegas Inmaculada , Amilibia Ane , Garcia Cristina , Rojo Jorge , Yoldi Alfredo

Background: Co secreting Thyrotropin/growth hormone pituitary adenomas are rare, and their clinical presentation and long term management may be challenging. Clinically, the majority of plurihormonal pituitary adenomas are silent and diagnosis almost always relies on immunohistochemical analysis of the tumor tissue. Early detection is key to optimize patient mamagement. We report a case of pituitary plurihormonal macroadenoma with overt clinical hyperthyroidism and minimal GH ...

ea0081ep107 | Adrenal and Cardiovascular Endocrinology | ECE2022

Cushing’s syndrome due to primary bilateral macronodular adrenal hyperplasia in medical treatment. A case report

Cebrian Susana Bacete , Trivino Vanessa , Abiega Beatriz Ugalde , Modamio Javier , Zubillaga Mikaela , Meizoso-Pita Olalla , Huguet Isabel , Moreno-Ruiz Inmaculada , Martin Timon Iciar , Sevillano-Collantes Cristina

Background: Primary bilateral bilateral macronodular adrenal hyperplasia is a cause of Cushing’s syndrome. It is characterised by a large enlargement of the adrenal glands at the expense of multiple non-pigmented nodules. There is inefficient steroidogenesis.Summary of the case: A 58-year-old woman with a history of extreme obesity, type 2 diabetes mellitus, hypertension and dyslipidaemia was admitted to our hospital for cellulitis and anaemia secon...

ea0081ep690 | Pituitary and Neuroendocrinology | ECE2022

Complete remision of nelson´s syndrome with cabergoline treatment

Egana Zunzunegui Nerea , Ortega Cristina Elias , Nebreda Inmaculada Venegas , Achucarro Ane Amilibia , Garay Ismene Bilbao , Calafell Maite Aramburu , Delgado Cristina Garcia , Arrieta Alfredo Yoldi

Introduction: Nelson´s Syndrome is defined as the presence of an enlarging pituitary tumor associated with elevated fasting plasma ACTH levels and hyperpigmentation in patients submitted to bilateral adrenalectomy for the treatment of Cushing´s disease. Case Report: We present a case of a 48 y/o woman who in 2015, was diagnosed of Cushing’s disease and underwent transsphenoidal adenomectomy but remission was not achieved, so the patient wa...

ea0081ep1080 | Thyroid | ECE2022

Neutropenia in hyperthyroidism

Elias Ortega Cristina , Zunzunegui Nerea Egan a , Delgado Cristina Garcia , Calafell Maria Teresa Aramburu , Alvaro Jorge Rojo , Nebreda Inmaculada Venegas , Achucarro Ane Amilibia , Garay Ismene Bilbao , Arrieta Alfredo Yoldi

Introduction: Neutropenia can indicate infectious and hematological pathology but it can also be a sign of hyperthyroidism. For this reason, it has been suggested to perform a complete blood count before starting treatment with antithyroid drugs in case of new-onset hyperthyroidism. Antithyroid drugs can cause severe neutropenia, also called agranulocytosis, when the neutrophil count is less than 500/µl. Therefore, the use of these drugs should be reconsidered if it is le...

ea0090ep151 | Calcium and Bone | ECE2023

Evaluation of the efficacy and safety of long-term Cinacalcet in primary hyperparathyroidism

Huguet Isabel , Timon Iciar Martin , Moreno-Ruiz Inmaculada , Yannuzzi Vanessa Trivino , Llavero Maria , Meizoso-Pita Olalla , Gargallo Fernandez Manuel Angel , Sevillano-Collantes Cristina

Introduction: Cinacalcet is a positive allosteric modulator of the calcium sensing receptor successfully used to decrease serum calcium in primary hyperparathyroidism (pHPT) patients in the short-term, but long-term data are scarce. In this single-centre retrospective analysis, we investigated the efficacy and safety of cinacalcet in pHPT patients who received more than 5 years of treatment.Methods: Statistical analysis was performed using free online so...

ea0090ep1138 | Late Breaking | ECE2023

Clinical spectrum of ectopic Cushing’s syndrome secondary to pheochromocytoma: A diagnostic and therapeutic challenge

Gomes Porras Mariana , Kishore Doulatram Gamgaram Viyey , Gonzalez Molero Inmaculada , Gonzalez Romero Stella , Carmen Bautista Recio Maria , Cruz Almaraz Almaraz Maria , Moreno-Torres Taboada Carolina , Olveira Fuster Gabriel

Introduction: The clinical presentation of ectopic Cushing’s syndrome secondary to pheochromocytoma differs from the classic manifestations of these endocrinopathies separately. This cosecretion causes greater morbidity, requiring a complex preoperative preparation. We describe two clinical cases, a 46-year-old male with grade II overweight and a 65-year-old female with grade I obesity, both with a personal history of hypertension poorly controlled with 7 and 3 antihypert...

ea0063p184 | Diabetes, Obesity and Metabolism 1 | ECE2019

Diagnosis of type 1 DM in a patient with Hydroxymethylglutaric aciduria: Case report

Doulatram Gamgaram Viyey Kishore , Marin Montserrat Gonzalo , Molero Inmaculada Gonzalez , Fernandez Jose Abuin , Torralvo Francisco Jose Sanchez , Adana Marisol Ruiz de , Fuster Gabriel Olveira

Introduction: Hydroxymethylglutaric aciduria is a rare metabolic disease that is caused by the deficiency of the enzyme 3-hydroxy-3-methylglutaryl-CoA lyase, which participates in the metabolism of leucine and in the formation of ketone bodies. The symptomatology usually occurs in the first two years of life and consists of nausea, vomiting, diarrhea, hypotoniaanddepressed level of consciousness. Metabolic acidosis occurs during crises as a result of the accumulation of metabo...